Health Canada
Symbol of the Government of Canada
Drugs and Health Products

Summary Basis of Decision (SBD) Documents: Drugs

The SBD documents explain why Health Canada authorized certain drugs for sale in Canada. The documents include regulatory, safety, effectiveness and quality (chemistry and manufacturing) considerations.

SBDs are published for New Drug Submissions that contain a new active substance(s) that were authorized after January 1, 2005. Health Canada will draft Phase II SBDs for all eligible drugs authorized as of September 1, 2012. Eligible products authorized before September 1, 2012, but on or after January 1, 2005, will have SBDs in the Phase I format.

The SBDs are organized alphabetically by product name. Use the following index, or see the list of SBDs for drugs below.

Reader's Guide

For an explanation of the information available in each section of a Phase I SBD, consult the Phase I Reader's Guide.

For an explanation of the information available in each section of a Phase II SBD, consult the Phase II Reader's Guide.

Other Resources

For up to date information on a particular product, readers should refer to the most recent Product Monograph, available on the searchable Drug Product Database.

For information related to Warnings, Recalls and Alerts, go to the MedEffect Canada web page.

Readers should refer to the Next link will take you to another Web site Food and Drugs Act and/or the Next link will take you to another Web site Food and Drug Regulations for more information about the regulation of drugs.

Readers may also wish to consult the Health Canada website for other policies and guidance documents related to drugs and drug submissions. In particular, readers may wish to refer to the Management of Drug Submissions Guidance.

Summary Basis of Decision Documents: Drugs

A

ABILIFY

ACTEMRA

  • Notice of Decision [2010-05-25]
  • Summary Basis of Decision [2010-10-04]

ADCETRIS

AFINITOR

ALOXI

ALREX

ALTARGO

ALVESCO

APIDRA

  • Notice of Decision [2007-01-05]
  • Summary Basis of Decision [2007-07-12]

APTIVUS

AREPANRIXTM H1N1

  • Notice of Decision [2009-10-21]
  • Summary Basis of Decision [2010-05-11]

ARZERRA

AREPANRIX H5N1

ATRIANCE

AVAMYS

AVASTIN

AZILECT

B

BANZEL

BARACLUDE

BENLYSTA

  • Notice of Decision [2011-08-30]
  • Summary Basis of Decision [2011-12-15]

BERINERT

  • Notice of Decision [2010-07-06]
  • Summary Basis of Decision [2011-01-06]

BESIVANCE

BEXXAR

BRILINTA

BYETTA

BYSTOLIC

C

CAMPRAL

CANTRACE

  • Notice of Decision [2006-12-13]
  • Summary Basis of Decision [2008-01-28]

CAPRELSA

CATENA

CAYSTON

CELSENTRI

CERVARIX

  • Notice of Decision [2010-09-02]
  • Summary Basis of Decision [2010-10-26]

CHAMPIX

CIMZIA

  • Notice of Decision [2009-09-24]
  • Summary Basis of Decision [2010-03-11]

CIVANEX

CLEVIPREX

CLOLAR

COLESEVELAM HYDROCHLORIDE (LODALIS)

COVERSYL

CUBICIN

CYMBALTA

D

DAXAS

DEXILANT

DIACOMIT

DIFICID

DORIBAX

E

EDARBI

EDURANT

EFFIENT

EFRACEA

ELAPRASE

ELIQUIS

ELOXATIN

EMEND

EMEND IV

EMTRIVA

ENABLEX

ERAXIS

ERBITUX

ESBRIET

EXELON PATCH

EXJADE

  • Notice of Decision [2007-01-17]
  • Summary Basis of Decision [2007-11-27]

F

FAMPYRA

FERAHEME

FINACEA

FIRMAGON

FLUMIST

  • Notice of Decision [2010-08-26]
  • Summary Basis of Decision [2011-01-10]

FOSRENOL

FYCOMPA

G

GARDASIL

GILENYA

H

HALAVEN

I

ILARIS

  • Notice of Decision [2010-04-09]
  • Summary Basis of Decision [2010-07-29]

INCIVEK

INFLUENZA A (H1N1) 2009 PANDEMIC MONOVALENT VACCINE (WITHOUT ADJUVANT)

  • Notice of Decision [2009-11-12]

INLYTA

INOMAX

INSPRA

INTELENCE

INVEGA

INVEGA SUSTENNA

ISENTRESS

IXIARO

  • Notice of Decision [2009-12-02]
  • Summary Basis of Decision [2010-07-20]

J

JAKAVI

JANUVIA

JEVTANA

K

KALYDECO

KEPIVANCE

KUVAN

L

LATUDA

LEUKOSCAN

LEVEMIR

LODALIS

LUCENTIS

  • Notice of Decision [2007-07-30]
  • Summary Basis of Decision [2007-12-21]

LUVERIS

LYRICA

M

MABCAMPATH

  • Notice of Decision [2006-08-11]
  • Summary Basis of Decision [2007-05-29]

MACUGEN

MENVEO

  • Notice of Decision [2010-06-23]
  • Summary Basis of Decision [2010-10-29]

METVIX

  • Notice of Decision [2009-03-17]
  • Summary Basis of Decision [2009-07-17]

MIRCERA

  • Notice of Decision [2008-07-03]
  • Summary Basis of Decision [2009-01-19]

MOZOBIL

MULTAQ

MYCAMINE

MYOZYME

  • Notice of Decision [2006-12-06]
  • Summary Basis of Decision [2007-07-30]

MYRBETRIQ

N

NATRECOR

  • Notice of Decision [2008-05-14]
  • Summary Basis of Decision [2007-11-08]

NEVANAC

NEXAVAR

NIMENRIX

NPLATE

  • Notice of Decision [2009-03-30]
  • Summary Basis of Decision for NPLATE [2009-07-21]

NUCYNTA CR

O

OLMETEC

OMNITROPE

  • Notice of Decision [2009-05-15]
  • Summary Basis of Decision [2009-09-14]

ONBREZ BREEZHALER

ONGLYZA

ORENCIA

  • Notice of Decision [2007-01-08]
  • Summary Basis of Decision [2007-05-07]

OXYNEO

P

PANTOLOC M

PICATO

POSANOL

POTIGA

PRADAX

PRECEDEX

PREVNAR 13

  • Notice of Decision [2010-01-30]
  • Summary Basis of Decision [2010-11-15]

PREXIGE

PREZISTA

PRIMOVIST

PRISTIQ

PROCHYMAL

PROLIA

  • Notice of Decision [2010-10-14]
  • Summary Basis of Decision [2011-01-17]

R

RAPAFLO

RAPTIVA

  • Notice of Decision [2006-08-02]
  • Summary Basis of Decision [2007-05-15]

RASILEZ

RECOTHROM

  • Notice of Decision [2010-02-10]
  • Summary Basis of Decision [2010-08-30]

RELISTOR

REMOVAB

RESOTRAN

REVLIMID

REVOLADE

ROTARIX

  • Notice of Decision [2008-01-04]
  • Summary Basis of Decision [2008-07-23]

ROTATEQ

  • Notice of Decision [2006-12-04]
  • Summary Basis of Decision [2007-06-04]

RUBY-FILL

S

SAMSCA

SAPHRIS

SEBIVO

SIMPONI

  • Notice of Decision [2009-05-21]
  • Summary Basis of Decision [2009-09-02]

SOLIRIS

  • Notice of Decision [2009-02-27]
  • Summary Basis of Decision [2009-07-22]

SOMATULINE AUTOGEL

SOMAVERT

  • Notice of Decision [2006-06-07]
  • Summary Basis of Decision [2006-11-06]

SPRYCEL

STELARA

  • Notice of Decision [2009-01-29]
  • Summary Basis of Decision [2009-05-27]

STIVARGA

STRIBILD

SUTENT

SWISH SILVER SUPREME

SYNFLORIX

  • Notice of Decision [2009-02-13]
  • Summary Basis of Decision [2009-06-16]

T

TARCEVA

TASIGNA

TECFIDERA

THELIN

TOCTINO

TORISEL

TOVIAZ

TRAJENTA

TRAMACET

TREANDA

TRETTEN

TROSEC

TYKERB

TYGACIL

TYSABRI

  • Notice of Decision [2007-04-19]
  • Summary Basis of Decision [2007-10-05]

U

ULORIC

V

VANTAS

VASOVIST

VECTIBIX

  • Notice of Decision [2008-06-25]
  • Summary Basis of Decision [2008-12-18]

VELCADE

VESICARE

VIBATIV

VICTOZA

  • Notice of Decision [2010-06-17]
  • Summary Basis of Decision [2010-10-26]

VICTRELIS

VIDAZA

VIMPAT

VISANNE

VOLIBRIS

VOLTAREN

VOTRIENT

VPRIV

  • Notice of Decision [2010-11-12]
  • Summary Basis of Decision [2011-02-25]

VYVANSE

X

XALKORI

XARELTO

XIAFLEX

XYREM

Y

YERVOY

YONDELIS

Z

ZEFTERA

ZELBORAF

ZELDOX

ZEMPLAR

ZEVALIN

ZOLINZA

ZYTIGA